Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (year values)

FY2016 FY2017 FY2018 FY2019 FY2020   LTM ?
EV/EBITDA ? 0.80 0.36 1.13 -11.8 -7.79   -5.35
Changes by years, y/y, % -55% +211% -1 148% -34%    

Constellation Pharmaceuticals. EV/EBITDA

Constellation Pharmaceuticals. EV/EBITDA, changes, %

Constellation Pharmaceuticals (CNST) EV/EBITDA US GAAP (quarter values)

FY2020Q1 FY2020Q2 FY2020Q3 FY2020Q4 FY2021Q1   LTM ?
EV/EBITDA ? -11.2 -8.19 -4.64 -7.75 -5.35   -5.35
Changes by years, y/y, % -898% -902% +235% -60% -52%    
Changes by quarters, q/q, % -43% -27% -43% +67% -31%    

Constellation Pharmaceuticals. EV/EBITDA

Constellation Pharmaceuticals. EV/EBITDA, changes, y/y, %

Constellation Pharmaceuticals. EV/EBITDA, changes, q/q, %